SAM CHUN DANG PHARM. CO., LTD.
三千堂製藥
Licensing announcements since 2025
| Date | Counterparty | Asset / platform | Upfront | Near-term | Potential total | Stage at announcement |
|---|---|---|---|---|---|---|
| 2026-02-19 | Apotex Inc. | Aflibercept biosimilar; new Middle East rights |
三千堂製藥
| Date | Counterparty | Asset / platform | Upfront | Near-term | Potential total | Stage at announcement |
|---|---|---|---|---|---|---|
| 2026-02-19 | Apotex Inc. | Aflibercept biosimilar; new Middle East rights |